Gene therapy, which is the delivery of DNA or RNA into cells to treat disease, is at the cutting edge of medical research, and often makes the headlines. Anna Gregson and Dean Houston at Mathys & Squire discuss the recent developments which have demonstrated the potential clinical impact that gene therapy can have in treating rare inherited diseases, as well as potentially some of the world’s most prevalent conditions.

[wonderplugin_pdf src=”https://www.biopharmaceuticalmedia.com/wp-content/uploads/2019/07/Gene-therapy_bubble-boy-and-beyond.pdf” width=”100%” height=”900px” style=”border:0;”]